| Pharmaceutical active ingredients: |
| Dexmethylphenidate Hydrochloride |
| Available forms, composition and doses of Focalin XR: |
| Capsules, Extended Release; Oral; Dexmethylphenidate Hydrochloride 10 mgCapsules, Extended Release; Oral; Dexmethylphenidate Hydrochloride 15 mgCapsules, Extended Release; Oral; Dexmethylphenidate Hydrochloride 20 mgCapsules, Extended Release; Oral; Dexmethylphenidate Hydrochloride 5 mgCapsules, Extended Release; Oral; Dexmethylphenidate Hydrochloride 25 mgCapsules, Extended Release; Oral; Dexmethylphenidate Hydrochloride 30 mgCapsules, Extended Release; Oral; Dexmethylphenidate Hydrochloride 35 mgCapsules, Extended Release; Oral; Dexmethylphenidate Hydrochloride 40 mg |
| Focalin XR medical category: |
| Human:Norepinephrine-dopamine reuptake inhibitorsPsychostimulantsReleasing agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N06BA11 - Dexmethylphenidate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Related documents and information about Focalin XR: |
| Focalin prescribing information (PDF)Focalin XR prescribing information (PDF) |